Cargando…

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer

The overall efficacy of neoadjuvant chemoradiotherapy (NACT) for locally advanced gastric cancer (LAGC) has been recognized. However, the response rate of NACT is limited due to tumor heterogeneity. For patients who are resistant to NACT, not only the operation timing will be postponed, patients wil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Juan, Wang, Xianze, Zhang, Zimu, Zeng, Ziyang, Ouyang, Siwen, Kang, Weiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085495/ https://www.ncbi.nlm.nih.gov/pubmed/33937042 http://dx.doi.org/10.3389/fonc.2021.641304

Ejemplares similares

The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
por: Ma, Mingwei, et al.
Publicado: (2022)

Comparison Among Endoscopic, Laparoscopic, and Open Resection for Relatively Small Gastric Gastrointestinal Stromal Tumors (<5 cm): A Bayesian Network Meta-Analysis
por: Liu, Zhen, et al.
Publicado: (2021)

OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

The Role and Mechanism of microRNA-1224 in Human Cancer
por: Ma, Mingwei, et al.
Publicado: (2022)

Correction: OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer
por: Zhang, Zimu, et al.
Publicado: (2022)

Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study
por: Zeng, Ziyang, et al.
Publicado: (2021)

Rare localization of angiolipoma in the gastrointestinal tract: a case series
por: Sun, Juan, et al.
Publicado: (2020)

The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma
por: Li, Jie, et al.
Publicado: (2022)

Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer
por: Zeng, Ziyang, et al.
Publicado: (2023)

A Machine Learning Model for Predicting a Major Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer
por: Chen, Yonghe, et al.
Publicado: (2021)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis
por: Zhu, Youqi, et al.
Publicado: (2023)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Lu, Ying, et al.
Publicado: (2022)

Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis
por: Liu, Zhen, et al.
Publicado: (2022)

Comparisons of nutritional status and complications between patients with and without postoperative feeding jejunostomy tube in gastric cancer: a retrospective study
por: Li, Kang, et al.
Publicado: (2023)

Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response
por: Lu, Jiatong, et al.
Publicado: (2023)

Multiparametric MRI radiomics fusion for predicting the response and shrinkage pattern to neoadjuvant chemotherapy in breast cancer
por: Fan, Ming, et al.
Publicado: (2023)

TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer
por: Liang, Hongling, et al.
Publicado: (2021)

M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study
por: Wang, Shu, et al.
Publicado: (2023)

A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy
por: Song, Dong, et al.
Publicado: (2021)

Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer
por: Guo, Jiabao, et al.
Publicado: (2022)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study
por: Wang, Xin, et al.
Publicado: (2022)

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer
por: Yang, Liping, et al.
Publicado: (2022)

Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer
por: Jiang, Lin, et al.
Publicado: (2021)

Case Report: Clinical application of continuous arterial infusion chemotherapy in neoadjuvant therapy for locally advanced gastric cancer
por: Lin, Wenli, et al.
Publicado: (2023)

The Correlation of Prediabetes and Type 2 Diabetes With Adiposity in Adults
por: Sun, Juan, et al.
Publicado: (2022)

Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer
por: Cai, Zhenghao, et al.
Publicado: (2020)

An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine
por: Wang, Mozhi, et al.
Publicado: (2021)

Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study
por: Xie, Kun, et al.
Publicado: (2022)

Quantitative Dynamic-Enhanced MRI and Intravoxel Incoherent Motion Diffusion−Weighted Imaging for Prediction of the Pathological Response to Neoadjuvant Chemotherapy and the Prognosis in Locally Advanced Gastric Cancer
por: Zhu, Yongjian, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
por: Dai, Huijuan, et al.
Publicado: (2021)

Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Kong, Xianshu, et al.
Publicado: (2022)

The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy
por: Sakin, Abdullah, et al.
Publicado: (2021)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)

Development of a MRI-Based Radiomics Nomogram for Prediction of Response of Patients With Muscle-Invasive Bladder Cancer to Neoadjuvant Chemotherapy
por: Zhang, Xinxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7lmq272svqc82i9luh1u9du2eb